Form 4 IGM Biosciences, Inc. For: Aug 08 Filed by: Strohl William
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
Morgan Stanley Reiterates Overweight Rating on IGM Biosciences (IGMS)
August 14, 2024 12:04 PM EDTMorgan Stanley analyst Michael Ulz reiterated an Overweight rating and $12.00 price target on IGM Biosciences (NASDAQ: IGMS)
The analyst comments "Reported 2Q24 highlighted progress across the early stage pipeline as Ph1b dose escalation continues for imvotamab in RA and... More

